151 related articles for article (PubMed ID: 30741932)
1. Identification of diterpenoid compounds that interfere with Fli-1 DNA binding to suppress leukemogenesis.
Liu T; Xia L; Yao Y; Yan C; Fan Y; Gajendran B; Yang J; Li YJ; Chen J; Filmus J; Spaner DE; Zacksenhaus E; Hao X; Ben-David Y
Cell Death Dis; 2019 Feb; 10(2):117. PubMed ID: 30741932
[TBL] [Abstract][Full Text] [Related]
2. Novel flavagline-like compounds with potent Fli-1 inhibitory activity suppress diverse types of leukemia.
Song J; Yuan C; Yang J; Liu T; Yao Y; Xiao X; Gajendran B; Xu D; Li YJ; Wang C; Liu W; Wen M; Spaner D; Filmus J; Zacksenhaus E; Zhang Y; Hao X; Ben-David Y
FEBS J; 2018 Dec; 285(24):4631-4645. PubMed ID: 30387554
[TBL] [Abstract][Full Text] [Related]
3. A screen for Fli-1 transcriptional modulators identifies PKC agonists that induce erythroid to megakaryocytic differentiation and suppress leukemogenesis.
Liu T; Yao Y; Zhang G; Wang Y; Deng B; Song J; Li X; Han F; Xiao X; Yang J; Xia L; Li YJ; Plachynta M; Zhang M; Yan C; Mu S; Luo H; Zacksenhaus E; Hao X; Ben-David Y
Oncotarget; 2017 Mar; 8(10):16728-16743. PubMed ID: 28052010
[TBL] [Abstract][Full Text] [Related]
4. The inositol phosphatase SHIP-1 is negatively regulated by Fli-1 and its loss accelerates leukemogenesis.
Lakhanpal GK; Vecchiarelli-Federico LM; Li YJ; Cui JW; Bailey ML; Spaner DE; Dumont DJ; Barber DL; Ben-David Y
Blood; 2010 Jul; 116(3):428-36. PubMed ID: 20445019
[TBL] [Abstract][Full Text] [Related]
5. Continuous Fli-1 expression plays an essential role in the proliferation and survival of F-MuLV-induced erythroleukemia and human erythroleukemia.
Cui JW; Vecchiarelli-Federico LM; Li YJ; Wang GJ; Ben-David Y
Leukemia; 2009 Jul; 23(7):1311-9. PubMed ID: 19282832
[TBL] [Abstract][Full Text] [Related]
6. Spi-1, Fli-1 and Fli-3 (miR-17-92) oncogenes contribute to a single oncogenic network controlling cell proliferation in friend erythroleukemia.
Kayali S; Giraud G; Morlé F; Guyot B
PLoS One; 2012; 7(10):e46799. PubMed ID: 23056458
[TBL] [Abstract][Full Text] [Related]
7. FLI1 promotes protein translation via the transcriptional regulation of MKNK1 expression.
Wang C; Song J; Liu W; Yao Y; Kapranov P; Sample KM; Gajendran B; Zacksenhaus E; Hao X; Ben-David Y
Int J Oncol; 2020 Feb; 56(2):430-438. PubMed ID: 31894299
[TBL] [Abstract][Full Text] [Related]
8. Synthetic siRNA targeting the breakpoint of EWS/Fli-1 inhibits growth of Ewing sarcoma xenografts in a mouse model.
Takigami I; Ohno T; Kitade Y; Hara A; Nagano A; Kawai G; Saitou M; Matsuhashi A; Yamada K; Shimizu K
Int J Cancer; 2011 Jan; 128(1):216-26. PubMed ID: 20648560
[TBL] [Abstract][Full Text] [Related]
9. The Fli-1 transcription factor regulates the expression of CCL5/RANTES.
Lennard Richard ML; Sato S; Suzuki E; Williams S; Nowling TK; Zhang XK
J Immunol; 2014 Sep; 193(6):2661-8. PubMed ID: 25098295
[TBL] [Abstract][Full Text] [Related]
10. Functional interference between retinoic acid or steroid hormone receptors and the oncoprotein Fli-1.
Darby TG; Meissner JD; Rühlmann A; Mueller WH; Scheibe RJ
Oncogene; 1997 Dec; 15(25):3067-82. PubMed ID: 9444955
[TBL] [Abstract][Full Text] [Related]
11. Spi-1 and Fli-1 directly activate common target genes involved in ribosome biogenesis in Friend erythroleukemic cells.
Juban G; Giraud G; Guyot B; Belin S; Diaz JJ; Starck J; Guillouf C; Moreau-Gachelin F; Morlé F
Mol Cell Biol; 2009 May; 29(10):2852-64. PubMed ID: 19289502
[TBL] [Abstract][Full Text] [Related]
12. miR-145 promotes osteosarcoma growth by reducing expression of the transcription factor friend leukemia virus integration 1.
Wu P; Liang J; Yu F; Zhou Z; Tang J; Li K
Oncotarget; 2016 Jul; 7(27):42241-42251. PubMed ID: 27304058
[TBL] [Abstract][Full Text] [Related]
13. The role of Fli-1 in normal cell function and malignant transformation.
Truong AH; Ben-David Y
Oncogene; 2000 Dec; 19(55):6482-9. PubMed ID: 11175364
[TBL] [Abstract][Full Text] [Related]
14. Fli-1 controls transcription from the MCP-1 gene promoter, which may provide a novel mechanism for chemokine and cytokine activation.
Lennard Richard ML; Nowling TK; Brandon D; Watson DK; Zhang XK
Mol Immunol; 2015 Feb; 63(2):566-73. PubMed ID: 25108845
[TBL] [Abstract][Full Text] [Related]
15. Current insights into the role of Fli-1 in hematopoiesis and malignant transformation.
Ben-David Y; Gajendran B; Sample KM; Zacksenhaus E
Cell Mol Life Sci; 2022 Feb; 79(3):163. PubMed ID: 35412146
[TBL] [Abstract][Full Text] [Related]
16. Fli-1 Activation through Targeted Promoter Activity Regulation Using a Novel 3', 5'-diprenylated Chalcone Inhibits Growth and Metastasis of Prostate Cancer Cells.
Ma Y; Xu B; Yu J; Huang L; Zeng X; Shen X; Ren C; Ben-David Y; Luo H
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210104
[TBL] [Abstract][Full Text] [Related]
17. The GATA-1 and Spi-1 transcriptional factors bind to a GATA/EBS dual element in the Fli-1 exon 1.
Barbeau B; Barat C; Bergeron D; Rassart E
Oncogene; 1999 Sep; 18(40):5535-45. PubMed ID: 10523830
[TBL] [Abstract][Full Text] [Related]
18. Caveolin-1 (CAV1) is a target of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing's sarcoma cells.
Tirado OM; Mateo-Lozano S; Villar J; Dettin LE; Llort A; Gallego S; Ban J; Kovar H; Notario V
Cancer Res; 2006 Oct; 66(20):9937-47. PubMed ID: 17047056
[TBL] [Abstract][Full Text] [Related]
19. Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.
Hensel T; Giorgi C; Schmidt O; Calzada-Wack J; Neff F; Buch T; Niggli FK; Schäfer BW; Burdach S; Richter GH
Oncotarget; 2016 Jan; 7(2):1451-63. PubMed ID: 26623725
[TBL] [Abstract][Full Text] [Related]
20. The Fli-1 proto-oncogene, involved in erythroleukemia and Ewing's sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members.
Zhang L; Lemarchandel V; Romeo PH; Ben-David Y; Greer P; Bernstein A
Oncogene; 1993 Jun; 8(6):1621-30. PubMed ID: 8502483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
